CPE logo

CPE

Asia, Beijing, China, Beijing

Description

CITIC Private Equity Funds Management is the strategic onshore private equity platform of CITIC Group and CITIC.

Investor Profile

CPE has made 34 investments, with 0 in the past 12 months and 26% as lead.

Stage Focus

  • Series C (24%)
  • Series B (15%)
  • Private Equity (15%)
  • Series D (15%)
  • Series A (12%)
  • Series E (9%)
  • Series Unknown (6%)
  • Series G (3%)
  • Series F (3%)

Country Focus

  • China (91%)
  • United States (6%)
  • Hong Kong (3%)

Industry Focus

  • Artificial Intelligence (Ai)
  • Health Care
  • Transportation
  • Biotechnology
  • E-commerce
  • Autonomous Vehicles
  • Manufacturing
  • Robotics
  • Public Transportation
  • Electronics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does CPE frequently co-invest with?

CICC
Asia, Beijing, China, Beijing
Co-Investments: 3
IDG Capital
Asia, Beijing, China, Beijing
Co-Investments: 5
Tencent
Asia, Guangdong, China, Shenzhen
Co-Investments: 3
GIC
Asia, Central Region, Singapore, Singapore
Co-Investments: 3
Temasek Holdings
Asia, Central Region, Singapore, Singapore
Co-Investments: 3
DST Global
Europe, England, United Kingdom, London
Co-Investments: 5
HongShan
Asia, Beijing, China, Beijing
Co-Investments: 7
Qiming Venture Partners
Asia, Shanghai, China, Shanghai
Co-Investments: 3
Coatue
North America, New York, United States, New York
Co-Investments: 3
Didi
Asia, Beijing, China, Haidian
Co-Investments: 3

Which angels does CPE often collaborate with?

Jun Lei
Asia, Beijing, China, Beijing
Shared Deals: 1

What are some of recent deals done by CPE?

Sangon Biotech

Shanghai, Shanghai, China

Sangon Biotech is engaged in the research and development of chemical synthesis of DNA.

BiotechnologyGenetics
Series UnknownApr 19, 2023
Amount Raised: $290,440,162
Jinyuansheng

Shanghai, Shanghai, China

Jinyuansheng is a supplier of new energy batteries.

Clean EnergyEnergy
Series BAug 15, 2022
Amount Raised: $147,634,163
Enflame

Shanghai, Shanghai, China

Enflame is an artificial intelligence start-up developing cloud-based deep learning chips for AI training platforms.

Artificial Intelligence (AI)Machine LearningSemiconductorSoftware
Series CAug 10, 2022
SiBionics

Shenzhen, Guangdong, China

SiBionics is a medtech company that engages in the field of chronic disease management.

Artificial Intelligence (AI)Health CareMedical Device
Series CJan 21, 2022
Amount Raised: $126,000,000
Chipone Technology

Beijing, Beijing, China

Chipone Technology is a chip design company engaged in the design of display chips for LED displays and LCD panels.

ElectronicsMobileProduct Design
Series EDec 15, 2021
Amount Raised: $1,020,792,763
GTA Semiconductor

Shanghai, Shanghai, China

GTA Semiconductor is a developer of semiconductor chips focusing on the R&D and design of integrated circuit related technologies.

ElectronicsManufacturingSemiconductor
Series UnknownNov 30, 2021
Amount Raised: $1,257,011,769
Wangdiantong

Beijing, Beijing, China

Wangdiantong is an E-commerce ERP management system that provides smart retail solutions for retailers digital transformation.

E-CommerceEnterprise Resource Planning (ERP)SaaS
Series DOct 28, 2021
Amount Raised: $312,000,000
Dreame Technology

Suzhou, Jiangsu, China

Dreame Technology produces premium hairdryers and vacuums in the style of Dyson.

ElectronicsManufacturingRetail
Series COct 21, 2021
Amount Raised: $563,089,484
Insilico Medicine

Hong Kong, Hong Kong Island, Hong Kong

Insilico Medicine develops an AI platform for drug development to treat cancer and age-related diseases.

Artificial Intelligence (AI)BiotechnologyHealth CarePharmaceutical
Series CJun 22, 2021
Amount Raised: $255,000,000
Biocytogen

Daxing, Beijing, China

Biocytogen is a biopharmaceutical company that provides integrated solutions for antibody drug development.

BiotechnologyHealth CareMedical DeviceTherapeutics
Series EJun 22, 2021